Prevention and treatment of Prevention and Treatment of Pre-eclampsia and Eclampsia

Analysis by the World Health Organization (WHO): Prevention and treatment of pre-eclampsia and eclampsia Prevention of pre-eclampsia and eclampsia by the World Health Organization (WHO) in completing work on community and world health by WHO I checked the guidelines for treatment. According to the guideline, hypertensive disorder of pregnancy is common, incidence is high. Although the purpose of this paper is to verify the validity and justification of the World Health Organization guidelines, we believe that these guidelines are effective, but the ability to develop guidelines in developing countries will be saved in life It is negligible though.

Recommendations for prevention include taking aspirin in a high-risk population, supplementing calcium in a low dose area, and treating hypertension with drug therapy. For patients with pre-eclampsia, delivery of infants and placenta is an effective treatment. When giving birth, it depends on the severity of preeclampsia and the extent to which a woman is pregnant. Blood pressure therapy drugs such as labetalol and methyldopa can be used to improve the condition of the mother before delivery. Magnesium sulphate can be used to prevent eclampsia of people suffering from severe illness. I do not know that ingestion of bed and salt is useful for treatment and prevention

The ultimate treatment for pre - eclampsia is the delivery of babies and placenta. Birth time should be balanced with the desire for the best results of the baby while reducing the risk of the mother. The severity of the disease and maturity of the baby are the main considerations. These considerations are case-specific and management depends on situation, location, and organization. In addition to drugs, treatment varies from expected treatment to induction of labor or promotion of labor by caesarean section. Evaluating the mother's organ system, management of severe hypertension, prevention and treatment of eclampsia is important in management. Individual intervention to the baby may also be necessary. Finding a break is useless, so we can not recommend it on a daily basis.

To prevent eclampsia, it is recommended to administer magnesium sulfate at birth and after birth of severe preeclampsia. In addition, magnesium sulfate is recommended for treatment of eclampsia compared to other anticonvulsants. Magnesium sulfate acts by interacting with NMDA receptors. Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality worldwide. Approximately one tenth of all deaths among pregnant women and mothers in Africa and Asia and a quarter of pregnant women in Latin America are related to pregnancy hypertension disorders including preeclampsia